StockData
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. (SLS) stock

SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$19.15+11.68 (+156.36%)

Close on Nov 17, 2026Market cap $3.87BP/E –Yield –

SELLAS Life Sciences gross margin

Gross margin is gross profit as a percentage of revenue.

SELLAS Life Sciences's gross margin for the twelve months ending Dec 31, 2022 was 90.0%. For fiscal 2022 it was 90.0%, against 97.4% the year before. The highest annual figure on record is 100.0% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 202290.0%−7.4
FY2021Dec 31, 202197.4%−2.6
FY2020Dec 31, 2020100.0%+15.1
FY2014Dec 31, 201484.9%+5.9
FY2013Dec 31, 201379.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2022Mar 31, 202290.0%–
Q2 FY2021Jun 30, 202194.7%–
Q1 FY2021Mar 31, 202198.2%–
Q4 FY2020Dec 31, 2020100.0%–

More SELLAS Life Sciences figures

See a number that looks wrong?